News and Events
December 14, 2011: NU SKIN ENTERPRISES ACQUIRES LIFEGEN TECHNOLOGIES
October 21, 2010: LifeGen Technologies Awarded NIH Grant to Identify Biomarkers of a Calorie Restricted Diet in Adipose Tissue
Caloric restriction is the only dietary intervention proven to increase both maximum and average lifespan in mammals, as well delaying age-related diseases. Because caloric restriction reduces body fat and markers of inflammation related to disease, it is thought that metabolic alterations in fat may underlie many of the health benefits associated with this dietary intervention. "Several decades of research support the concept of caloric restriction as an effective intervention in aging retardation. This research grant clearly validates the enormous potential of LifeGen's technology in discovering the next generation of anti-aging compounds, based on caloric restriction science," said LifeGen cofounder and Chief Scientific Officer Dr. Tomas A. Prolla.
October 22, 2009: NU SKIN SIGNS RESEARCH AGREEMENT WITH LIFEGEN TECHNOLOGIES
Nu Skin will collaborate with LifeGen in an exclusive agreement by leveraging LifeGen’s proprietary methods regarding gene expression profiling and pathways affected by aging. LifeGen's pioneering research has resulted in several pending patents, and ongoing research undertaken in collaboration with Nu Skin is expected to yield further important intellectual property. LifeGen’s patent for the use of "gene expression profiling" as a method to measure the aging process at the molecular level in individual organs will be a key component of the partnership.
January 2009: LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie restriction
July 2008: LifeGen researchers report that short-term treatment of mice with a commerically-available nutraceutical mixture containing a low dose of resveratrol mimics the cardiac gene expression profile of mice subjected to long-term calorie restriction. The study was published online in the "Articles in Press" section of the journal Experimental Gerontology
June 2008: Landmark publication describing the effect of a low dose of resveratrol on the gene expression profile of normal aging. LifeGen scientists reported a striking overlap in gene expression between mice treated with resveratrol and mice consuming a calorie-restricted diet. Full text of the study is available at http://www.plosone.org/doi/pone.0002264
April 2004: Chasing The Youth Pill Drugs that might extend human life are one of the hottest topics in biotech. Some of them are already here. (FORTUNE Magazine)
February 2002: LifeGen Technologies appoints its Board of Directors
November 2001: LifeGen Technologies is founded as a LLC.